MX2021005077A - Peptidos y composiciones farmaceuticas para tratar enfermedades oculares. - Google Patents
Peptidos y composiciones farmaceuticas para tratar enfermedades oculares.Info
- Publication number
- MX2021005077A MX2021005077A MX2021005077A MX2021005077A MX2021005077A MX 2021005077 A MX2021005077 A MX 2021005077A MX 2021005077 A MX2021005077 A MX 2021005077A MX 2021005077 A MX2021005077 A MX 2021005077A MX 2021005077 A MX2021005077 A MX 2021005077A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical compositions
- eye diseases
- peptides
- treating eye
- peptide compounds
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 208000030533 eye disease Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 210000004087 cornea Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Immunology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862767180P | 2018-11-14 | 2018-11-14 | |
| PCT/IB2019/001220 WO2020099925A2 (en) | 2018-11-14 | 2019-11-14 | Peptides and pharmaceutical compositions for treating eye diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021005077A true MX2021005077A (es) | 2021-08-11 |
Family
ID=70732068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021005077A MX2021005077A (es) | 2018-11-14 | 2019-11-14 | Peptidos y composiciones farmaceuticas para tratar enfermedades oculares. |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3880690A4 (enExample) |
| JP (1) | JP7522732B2 (enExample) |
| KR (1) | KR20210087539A (enExample) |
| CN (1) | CN113474356B (enExample) |
| AU (1) | AU2019378162B2 (enExample) |
| BR (1) | BR112021009341A2 (enExample) |
| MX (1) | MX2021005077A (enExample) |
| SG (1) | SG11202104178TA (enExample) |
| TW (1) | TWI865470B (enExample) |
| WO (1) | WO2020099925A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12037415B2 (en) | 2017-05-17 | 2024-07-16 | Yuyu Pharma, Inc. | Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient |
| US11613558B2 (en) | 2018-11-14 | 2023-03-28 | Yuyu Pharma, Inc. | Peptides and pharmaceutical compositions for treating eye diseases |
| BR112021023477A2 (pt) | 2019-05-21 | 2022-02-15 | Eyebio Korea | Novo composto peptídico, composição farmacêutica para prevenir ou tratar inflamação, composição de alimento para prevenir ou amenizar a inflamação e composição de cosmético tendo um efeito anti inflamatório |
| WO2021191689A2 (en) * | 2020-03-05 | 2021-09-30 | Yuyu Pharma, Inc. | Treatment of inflammatory diseases with peptides and pharmaceutical compositions |
| MX2024006997A (es) * | 2021-12-13 | 2024-06-19 | Eyebiokorea Inc | Composicion para el tratamiento de la degeneracion macular que comprende un nuevo peptido. |
| KR102662922B1 (ko) * | 2022-05-31 | 2024-05-03 | 주식회사 세네릭스 | 신규의 d-아미노산 유도체 및 이를 포함하는 약학 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6037135A (en) * | 1992-08-07 | 2000-03-14 | Epimmune Inc. | Methods for making HLA binding peptides and their uses |
| KR101690539B1 (ko) * | 2015-07-30 | 2016-12-29 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 약학조성물 |
| ES2822289T3 (es) * | 2016-04-08 | 2021-04-30 | Eyebio Korea | Péptido a base de colágeno tipo II alfa-1 para su uso en el tratamiento de la degeneración macular |
| KR101795653B1 (ko) * | 2016-05-19 | 2017-11-09 | 인제대학교 산학협력단 | 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물 |
| KR20180074928A (ko) * | 2016-12-26 | 2018-07-04 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 동물 의약품 조성물 |
| US12037415B2 (en) * | 2017-05-17 | 2024-07-16 | Yuyu Pharma, Inc. | Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient |
-
2019
- 2019-11-13 TW TW108141290A patent/TWI865470B/zh active
- 2019-11-14 SG SG11202104178TA patent/SG11202104178TA/en unknown
- 2019-11-14 WO PCT/IB2019/001220 patent/WO2020099925A2/en not_active Ceased
- 2019-11-14 CN CN201980078779.XA patent/CN113474356B/zh active Active
- 2019-11-14 MX MX2021005077A patent/MX2021005077A/es unknown
- 2019-11-14 BR BR112021009341-9A patent/BR112021009341A2/pt unknown
- 2019-11-14 KR KR1020217018226A patent/KR20210087539A/ko not_active Ceased
- 2019-11-14 JP JP2021526304A patent/JP7522732B2/ja active Active
- 2019-11-14 AU AU2019378162A patent/AU2019378162B2/en active Active
- 2019-11-14 EP EP19883897.1A patent/EP3880690A4/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN113474356A (zh) | 2021-10-01 |
| WO2020099925A3 (en) | 2020-06-25 |
| KR20210087539A (ko) | 2021-07-12 |
| TWI865470B (zh) | 2024-12-11 |
| EP3880690A2 (en) | 2021-09-22 |
| JP2022507404A (ja) | 2022-01-18 |
| SG11202104178TA (en) | 2021-05-28 |
| JP7522732B2 (ja) | 2024-07-25 |
| TW202031675A (zh) | 2020-09-01 |
| BR112021009341A2 (pt) | 2021-08-10 |
| EP3880690A4 (en) | 2023-09-13 |
| CN113474356B (zh) | 2024-12-17 |
| WO2020099925A2 (en) | 2020-05-22 |
| CA3119921A1 (en) | 2020-05-22 |
| AU2019378162B2 (en) | 2025-01-30 |
| AU2019378162A1 (en) | 2021-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2020099925A3 (en) | Peptides and pharmaceutical compositions for treating eye diseases | |
| IL272105A (en) | Local administration of pharmaceutical agents containing cell-penetrating peptides for use in the treatment of age-related macular degeneration and other eye diseases | |
| MX2023003124A (es) | Composiciones farmaceuticas oftalmicas y usos que se relacionan a las mismas. | |
| MX2019006432A (es) | Conjugados que comprenden un agonista dual de glp-1/glucagon, un enlazador y acido hialuronico. | |
| EP4566651A3 (en) | Ophthalmic delivery device | |
| MX378707B (es) | Compuestos para el tratamiento de enfermedades y trastornos oftalmicos. | |
| MX2019013799A (es) | Peptido novedoso y composicion farmaceutica para tratar una enfermedad ocular que comprende el mismo como un ingrediente farmaceutico activo. | |
| MX2019008963A (es) | Composicion para la prevencion o el tratamiento de deterioros visuales que comprenden acido ursodesoxicolico. | |
| MY176514A (en) | Compositions and methods for treating ocular edema, neovascularization and related diseases | |
| EA201691402A1 (ru) | Фармацевтический препарат, содержащий соединение пиридиламиноуксусной кислоты | |
| EA202191684A1 (ru) | Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии | |
| EA202190057A1 (ru) | Солюбилизированные апиразы, способы и применение | |
| WO2014161004A3 (en) | Compositions and methods for the delivery of drugs to the ocular surface by contact lenses | |
| MY178169A (en) | Topical ophthalmic peptide formulation | |
| CL2020001426A1 (es) | Composición tópica oftálmica que comprende ácido dobesilico para tratar enfermedades del segmento posterior del ojo. | |
| MX2020013692A (es) | Compuestos de pirazol e imidazol para la inhibicion de il-17 y rorgamma. | |
| EP4338751A3 (en) | Medicament comprising combination of sepetaprost and rho-associated coiled-coil containing protein kinase inhibitor | |
| EA201690903A1 (ru) | Лечение глаукомы с использованием лаквинимода | |
| HK1252301A2 (zh) | 一种含有重组人溶菌酶的新型人工泪液 | |
| EP4691493A3 (en) | Compositions for treating eye diseases | |
| RU2014106328A (ru) | Фармацевтические композиции, содержащие 4-бром-n-(имидазолидин-2-илиден)-1н-бензимидазол-5-амин для лечения заболеваний сетчатки | |
| MX2024005327A (es) | Composiciones y metodos de dsg2. | |
| MY184873A (en) | Therapeutic agent for sjogren's syndrome dry eye | |
| MX2017012999A (es) | Acido pirrolidona carboxilico (pca) para uso oftalmico. | |
| MX2022009136A (es) | Composicion farmaceutica oftalmica y uso de la misma. |